Should you buy Cigna stock now?
Yes, the technical signal for Cigna is currently Strong Buy. Cigna trades at $295.60 as of Nov 10, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 3.478 with falling momentum (signal: 4.838); RSI is at 51.3 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $342.56 points to 15.9% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Cigna stock?
The average analyst price target for Cigna is $342.56. The current price is $295.60, which gives an upside of 15.9%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $308.30 and $376.82.
Is Cigna a dividend stock?
Yes, Cigna is a dividend stock with a dividend yield of 2.05%. The latest dividend was $1.56 per share. The latest ex-dividend date (traded without the dividend) was Dec 3, 2026. The payout ratio is 19.7%, which is considered sustainable. The next dividend payment is scheduled for Dec 17, 2026.
When does Cigna pay a dividend in 2026?
Cigna pays its next dividend on Dec 17, 2026. The latest dividend was $1.56 per share with an ex-dividend date of Dec 3, 2026. The dividend yield is 2.05%. The payout ratio of 19.7% points to a sustainable dividend with room to grow.
What is the risk of Cigna stock?
Cigna is rated as a stock in the risk category Balanced. the annual standard deviation is 26.8%, which classifies the stock as Balanced.
Is Cigna overvalued?
No, Cigna is considered undervalued based on the analyst price target (15.9% upside). Cigna has the following valuation ratios: a P/E ratio of 12.9 (moderately valued), a P/S ratio of 0.3, a P/B ratio of 1.8. The analyst price target suggests that the stock is undervalued by 15.9%.
Is Cigna overbought?
No, Cigna is not overbought. RSI is at 51.3 (neutral zone). The technical indicators show: RSI is at 51.3 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 1.3% below the 20-day average (short-term downtrend). In addition, MACD is positive, but momentum is falling.
When is the next Cigna earnings report?
The date of the next earnings report for Cigna has not been published yet. Check the company's investor calendar for updates.
Is Cigna shorted?
Yes, Cigna is shorted with 2.9% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Cigna stock?
No, insiders are not buying Cigna shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 2 sales. On a net basis, 923,775 USD worth of shares were sold. Across the last 20 reported transactions, the split is 1 purchases and 19 sales, with a net 65,765,888 USD sold. Active sellers include Neville Everett, Jones Nicole S, Kates Jamie G and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Cigna a good stock?
Based on our total score, Cigna is rated as a good stock with a total score of 75 out of 100. The stock scores above average on value, quality and momentum. The score is made up of Value: 88/100, Quality: 61/100, Momentum: 78/100. In addition: analysts see 15.9% upside to the price target; a dividend of 2.05%. Whether now is the time to buy is a separate question: the technical signal is Strong Buy. Whether Cigna is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Cigna stock?
The outlook for Cigna based on current data: the average analyst price target is $342.56 (+15.9%); the stock is in an uptrend (above SMA50 and SMA200); the P/E ratio is 12.9 (low – a possible value stock). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Cigna stock moving?
Cigna is stable right now. The technical indicators show: the price is close to the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Cigna go?
The average analyst price target for Cigna is $342.56, which corresponds to a potential gain of 15.9% from the current price of $295.60. The stock has traded between $253.76 and $318.05 over the last 52 weeks. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Cigna fall?
The stock has traded as low as $253.76 over the last 52 weeks — that is 14.2% below the current price of $295.60. The biggest decline (drawdown) in the same period was 20.2% from high to low. Within a year, the price typically swings about ±26.8% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Cigna do?
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Service... The company belongs to the Healthcare sector, more specifically the Healthcare Plans industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Cigna as an investment.
Did Cigna raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Cigna. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Cigna making money or losing money?
Yes, Cigna is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 2.1% — which is modest. The operating margin (profit before interest and taxes) is 3.5%. At a P/E ratio of 12.9, you currently pay 12.9 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Cigna go bankrupt?
The bankruptcy risk of Cigna is rated as moderate. Altman Z2 (a model for assessing financial distress) is 1.51 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 8 — which is strong. Debt relative to equity is 279% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Cigna have a lot of debt?
Yes, Cigna has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 279%. For the healthcare sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Cigna service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 7.3x, and net debt equals 2.0 years of earnings (EBITDA).